Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Glenmark Life Sciences Ltd - 543322 - Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31, 2022

 Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that the Board at its meeting held today approved the Unaudited Financial Results for the Third Quarter and Nine Months ended December 31, 2022. The said meeting of the Board commenced at 11.00 a.m. and concluded at 12.30 p.m. The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith. These are also being made available on the website of the Company at www.glenmarklifesciences.com You are requested to take the same on record.
27-01-2023
Bigul

Glenmark Life Sciences Ltd - 543322 - Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31, 2022

 Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that the Board at its meeting held today approved the Unaudited Financial Results for the Third Quarter and Nine Months ended December 31, 2022. The said meeting of the Board commenced at 11.00 a.m. and concluded at 12.30 p.m. The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith. These are also being made available on the website of the Company at www.glenmarklifesciences.com You are requested to take the same on record.
27-01-2023
Bigul

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Enclosed please find herewith the details of Earnings Call slated for Friday, January 27, 2023 at 4:30 p.m. - 5:30 p.m. (IST), for your information and record.
18-01-2023
Bigul

Glenmark Life Sciences Ltd - 543322 - Closure of Trading Window

 We have to inform you that, pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, a meeting of the Board of Directors will be held on Friday, January 27, 2023, inter alia, to consider and approve the Unaudited Financial Results of the Company for the Third quarter and Nine months ended December 31, 2022. Further, as per the "Code of Conduct for Prevention of Insider Trading" and pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 the Company has intimated its Directors and other designated persons regarding the closure of trading window from December 31, 2022 to January 29, 2023 (both days inclusive) for the purpose of approval of Unaudited Financial Results for the Third quarter and Nine months ended December 31, 2022.
13-01-2023
Bigul

Glenmark Life Sciences Ltd - 543322 - Board Meeting Intimation for Unaudited Financial Results Of The Company For The Third Quarter And Nine Months Ended December 31, 2022

 Glenmark Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2023 ,inter alia, to consider and approve We have to inform you that, pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, a meeting of the Board of Directors will be held on Friday, January 27, 2023, inter alia, to consider and approve the Unaudited Financial Results of the Company for the Third quarter and Nine months ended December 31, 2022. Further, as per the "Code of Conduct for Prevention of Insider Trading" and pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 the Company has intimated its Directors and other designated persons regarding the closure of trading window from December 31, 2022 to January 29, 2023 (both days inclusive) for the purpose of approval of Unaudited Financial Results for the Third quarter and Nine months ended December 31, 2022.
13-01-2023
Bigul

Glenmark Life Sciences Ltd - 543322 - Minutes Of The Resolutions Passed By Way Of Postal Ballot Through Remote E-Voting

 Minutes of the Resolutions passed by way of Postal Ballot through remote e-voting
13-01-2023
Bigul

Glenmark Life Sciences Ltd - 543322 - Result Of Postal Ballot & Scrutinizer''s Report

 Further to our letter dated 2nd December, 2022 regarding notice of Postal Ballot, please find enclosed herewith the following - 1. Voting Result as required under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; and 2. Scrutinizer's Report dated 3rd January, 2023. Based on the Scrutinizer's Report, we wish to inform you that the Ordinary Resolutions mentioned in the said Postal Ballot notice have been passed by the members of the Company with requisite majority. The voting result along with the Scrutinizer's Report is also being made available on the Company's website.
03-01-2023
Bigul

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspaper Advertisement - Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
03-12-2022
Bigul

Glenmark Life Sciences Ltd - 543322 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

 Intimation regarding Notice of Postal Ballot - Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations')
02-12-2022
Bigul

Glenmark Life Sciences: Why you can buy this stock now

 Valuation correction provides comfort in owning the stock, which is currently trading at 422.85
26-11-2022
Next Page
Close

Let's Open Free Demat Account